BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11274763)

  • 1. Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-dependent adhesion to fibronectin and VCAM-1 on bone marrow hematopoietic progenitor cells.
    Hidalgo A; Sanz-Rodríguez F; Rodríguez-Fernández JL; Albella B; Blaya C; Wright N; Cabañas C; Prósper F; Gutierrez-Ramos JC; Teixidó J
    Exp Hematol; 2001 Mar; 29(3):345-55. PubMed ID: 11274763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chemokine SDF-1alpha suppresses fibronectin-mediated in vitro lymphocytes adhesion.
    Lili J; Yuchen S; Zhengtao W
    Mol Cells; 2006 Dec; 22(3):308-13. PubMed ID: 17202859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemokine GRObeta mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment.
    Fukuda S; Bian H; King AG; Pelus LM
    Blood; 2007 Aug; 110(3):860-9. PubMed ID: 17416737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells.
    Dar A; Schajnovitz A; Lapid K; Kalinkovich A; Itkin T; Ludin A; Kao WM; Battista M; Tesio M; Kollet O; Cohen NN; Margalit R; Buss EC; Baleux F; Oishi S; Fujii N; Larochelle A; Dunbar CE; Broxmeyer HE; Frenette PS; Lapidot T
    Leukemia; 2011 Aug; 25(8):1286-1296. PubMed ID: 21494253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomaterial-enabled delivery of SDF-1α at the ventral side of breast cancer cells reveals a crosstalk between cell receptors to promote the invasive phenotype.
    Liu XQ; Fourel L; Dalonneau F; Sadir R; Leal S; Lortat-Jacob H; Weidenhaupt M; Albiges-Rizo C; Picart C
    Biomaterials; 2017 May; 127():61-74. PubMed ID: 28279922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered responsiveness to chemokines due to targeted disruption of SHIP.
    Kim CH; Hangoc G; Cooper S; Helgason CD; Yew S; Humphries RK; Krystal G; Broxmeyer HE
    J Clin Invest; 1999 Dec; 104(12):1751-9. PubMed ID: 10606629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of tumor necrosis factor alpha and very late activation antigen 4/vascular cell adhesion molecule 1 interaction in surgical-stress-enhanced experimental metastasis.
    Higashiyama A; Watanabe H; Okumura K; Yagita H
    Cancer Immunol Immunother; 1996 May; 42(4):231-6. PubMed ID: 8665570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of stromal-cell derived factor-1 in the development of autoimmune diseases in non-obese diabetic mice.
    Matin K; Salam MA; Akhter J; Hanada N; Senpuku H
    Immunology; 2002 Oct; 107(2):222-32. PubMed ID: 12383202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of SRC-mediated integrin signaling in bone marrow niche enhances hematopoietic stem cell function.
    Roy IM; Anu PV; Zaunz S; Reddi S; Giri AM; Sankar RS; Schouteden S; Huelsken J; Verfaillie CM; Khurana S
    iScience; 2022 Oct; 25(10):105171. PubMed ID: 36204266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing.
    Alvarez P; Carrillo E; Vélez C; Hita-Contreras F; Martínez-Amat A; Rodríguez-Serrano F; Boulaiz H; Ortiz R; Melguizo C; Prados J; Aránega A
    Biomed Res Int; 2013; 2013():312656. PubMed ID: 23844360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.
    Rettig MP; Ansstas G; DiPersio JF
    Leukemia; 2012 Jan; 26(1):34-53. PubMed ID: 21886173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DEK, a nuclear protein, is chemotactic for hematopoietic stem/progenitor cells acting through CXCR2 and Gαi signaling.
    Capitano ML; Sammour Y; Ropa J; Legendre M; Mor-Vaknin N; Markovitz DM
    J Leukoc Biol; 2022 Sep; 112(3):449-456. PubMed ID: 35137444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.
    Kaplan RN; Riba RD; Zacharoulis S; Bramley AH; Vincent L; Costa C; MacDonald DD; Jin DK; Shido K; Kerns SA; Zhu Z; Hicklin D; Wu Y; Port JL; Altorki N; Port ER; Ruggero D; Shmelkov SV; Jensen KK; Rafii S; Lyden D
    Nature; 2005 Dec; 438(7069):820-7. PubMed ID: 16341007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of very late antigen-4 (VLA-4, alpha4beta1 integrin) allosteric antagonists.
    Chigaev A; Wu Y; Williams DB; Smagley Y; Sklar LA
    J Biol Chem; 2011 Feb; 286(7):5455-63. PubMed ID: 21131351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells, used as bait, disclose tissue binding sites: a tool in the search for the niche?
    Ratliff BB; Singh N; Yasuda K; Park HC; Addabbo F; Ghaly T; Rajdev M; Jasmin JF; Plotkin M; Lisanti MP; Goligorsky MS
    Am J Pathol; 2010 Aug; 177(2):873-83. PubMed ID: 20558574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2.
    Abonia JP; Austen KF; Rollins BJ; Joshi SK; Flavell RA; Kuziel WA; Koni PA; Gurish MF
    Blood; 2005 Jun; 105(11):4308-13. PubMed ID: 15705791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bitter Taste Receptor Agonist Denatonium Inhibits Stemness Characteristics in Hematopoietic Stem/Progenitor Cells.
    Pensato V; Laginestra MA; Falvo P; Orecchioni S; Talarico G; De Marchi E; Bruno S; Mongiorgi S; Mitola G; Bertolini F; Adinolfi E; Cavo M; Curti A; Salvestrini V
    Stem Cells; 2024 Jan; 42(1):42-54. PubMed ID: 37798139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in chemotaxis to fibronectin in weakly and highly metastatic tumor cells.
    Murata J; Saiki I; Yoneda J; Azuma I
    Jpn J Cancer Res; 1992 Dec; 83(12):1327-33. PubMed ID: 1483947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HAPLN1 matrikine: a bone marrow homing factor linked to poor outcomes in patients with MM.
    Chang HY; Huynh M; Roopra A; Callander NS; Miyamoto S
    Blood Adv; 2023 Nov; 7(22):6859-6872. PubMed ID: 37647592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genetic lesion that arrests plasma cell homing to the bone marrow.
    Erickson LD; Lin LL; Duan B; Morel L; Noelle RJ
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12905-10. PubMed ID: 14555759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.